E. Almahasnah

BMS-936564 (Anti-CXCR4 Antibody) Induces Specific Leukemia Cell Mobilization and Objective Clinical Responses In CLL Patients Treated Under a Phase I Clinical Trial

T. Kipps, P. Sabbatini, J. Castro, 2013 .

Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia

T. Kipps, J. Chang, J. Castro, 2014, Blood Cancer Journal.

and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.

J. Chang, E. Almahasnah, M. Choi, 2014 .

A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry.

S. Hindawi, M. Badawi, G. Elgohary, 2023, Journal of clinical apheresis.